← Evidence map

ReviewOncogene2002

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.

Frederic J KayePubMed ↗Publisher ↗

No numbers read from the abstract.

73 papers cite itlatest 60 shown

2002
…
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 12362273